| --- | --- | --- | --- | --- | |--------------------------------|-------|---------------------------------------------------------------|-------|---------------------------------------------------------| | | | | | | | | | | | | | | | CANTON | | Catalyst Pharmaceuticals VIRTUAL GLOBAL HEALTHCARE 2021 | | | | | | | | Alle SMILE SMAN AND AMERICAN 1 | | SMILLER COMME SMILLE ssiller Allin SMILLe SMILLE Ship Million | | | Safe Harbor This presentation contains forward‐looking statements that are subject to a num ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q2 2021 Earnings Conference Call August 10, 2021 8:30 AM ET Company Participants Ali Grande - Chief Financial Officer Patrick McEnany - Chairman and Chief Executive Officer Steven Miller - Chief Operating Officer and Chief Scientific Officer Jeffrey Del Carmen - Chief Commercial Officer Gary Ingenito - Chief Medical and Regulatory Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Operator Greetings and welcome to the Catalyst Pharmaceuticals ...

Table of Contents Title of Each ClassTicker SymbolName of Exchange on Which Registered Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market Emerging growth company ☐ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Alicia Grande – Vice President, Chief Financial Officer and Treasurer Patrick McEnany – Chairman and Chief Executive Officer Jeffrey Del Carmen – Chief Commercial Officer Steven Miller – Chief Operating Officer and Chief Scientific Officer Brian Elsbernd – Chief Legal and Compliance Officer Conference Call Participants Charles Duncan – Cantor Fitzgerald Leszek Sulewski – Truist Operator ...

Table of Contents Title of Each ClassTicker SymbolName of Exchange on Which Registered Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2021 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 00 ...

Start Time: 08:30 January 1, 0000 9:18 AM ET Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2020 Earnings Conference Call March 16, 2021, 08:30 AM ET Company Participants Patrick McEnany - Co-Founder, Chairman and CEO Alicia Grande - VP, CFO and Treasurer Steven Miller - COO and Chief Scientific Officer Jeff Del Carmen - Chief Commercial Officer Conference Call Participants Joe Catanzaro - Piper Sandler Charles Duncan - Cantor Fitzgerald Les Sulewski - Truist Securities Scott Henry - ROTH Capital Operator ...

Table of Contents Title of Each ClassTicker SymbolName of Exchange on Which Registered Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 0 ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q3 2020 Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Alicia Grande - Chief Financial Officer Patrick McEnany - Chairman & Chief Executive Officer Steven Miller - Chief Operating Officer & Chief Scientific Officer Jeffrey Del Carmen - Chief Commercial Officer Conference Call Participants Joe Catanzaro - Piper Sandler Charles Duncan - Cantor Fitzgerald Scott Henry - Roth Capital Operator Greetings and welcome to Catalyst Pharmaceutical ...

Table of Contents Title of Each ClassTicker SymbolName of Exchange on Which Registered Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2020 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q2 2020 Earnings Conference Call August 11, 2020 8:30 AM ET Company Participants Alicia Grande - Chief Financial Officer Patrick McEnany - Chairman and Chief Executive Officer Jeffrey Del Carmen - Chief Commercial Officer Steven Miller - Chief Operating Officer and Chief Scientific Officer Gary Ingenito - Chief Medical Regulatory Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Leland Gershell - Oppenheimer Operator Hello and welcome to the ...